Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01700959 · ClinicalTrials.gov registry record · Phase 3
Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort
A Phase 3 study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 911
- Enrollment target
NCT01700959 is a Phase 3 study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 911 participants.
The verdict
NCT01700959, a Phase 3 study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 911 participants
- Enrollment target
Study Summary
Primary objective: 1. To examine the efficacy of melatonin treatment on neurocognitive functioning in adult survivors of childhood cancer. Secondary objectives: 1. To evaluate the efficacy of melatonin treatment on delayed sleep onset latency in long-term childhood cancer survivors. 2. To investigate whether improvement in sleep onset latency due to melatonin treatment is associated with neurocognitive improvement in long-term childhood cancer survivors. This study is a randomized double-blind placebo controlled trial of time release melatonin for adult survivors of childhood cancer who demonstrate impaired neurocognitive functioning and/or difficulty falling asleep.
Interventions
- DRUG placebo
- DRUG melatonin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 911 participants |
| Start Date | 2013-02-06 |
| Est. Completion | 2017-04-19 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01700959
The ClinicalTrials.gov registry entry for NCT01700959 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 911 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01700959 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01700959 about?
NCT01700959 is a clinical study titled "Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort". Primary objective: 1. To examine the efficacy of melatonin treatment on neurocognitive functioning in adult survivors of childhood cancer. Secondary objectives: 1. To evaluate the efficacy of melatonin treatment on delayed sleep onset latency in long-term childhood cancer survivors. 2. To investi...
What is the current status of trial NCT01700959?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 911 participants. The study started on 2013-02-06. Estimated completion is 2017-04-19.
What interventions are being tested in trial NCT01700959?
The interventions under investigation include: placebo (DRUG), melatonin (DRUG).
Who is sponsoring clinical trial NCT01700959?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.